FDA approves first ever Friedreich’s ataxia drug treatment
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
The Norman Fixel Institute and Dr. Okun among those featured for PBS NewsHour segment on arts in medicine.
The Harry T. Mangurian Jr. Foundation supported grants for two Lewy body dementia pilot studies.
Experts at the Norman Fixel Institute for Neurological Diseases hosted the 8th annual Deep Brain Stimulation Think Tank.
By studying superagers, people 90 and older in good health, researchers hope to uncover the keys to successful aging.
Reporters from Suncoast News Network, a Sarasota TV station, followed the journey of UF Health patient PJ Delaney.